Madelon M.E. de Jong
- Co-authors
- Tom CupedoRemco M. HoogenboezemMathijs A. SandersPieter C. van de WoestijneZoltán KellermayerSabrin TahriPhilippe MoreauPieter Sonneveld
- Topics
- Multiple Myeloma Research and Treatments (9 papers)Chemokine receptors and signaling (9 papers)Immune cells in cancer (5 papers)
- Cited by
- HematologyImmunologyOncology
- Partner nations
- NetherlandsItalyGermany
In The Last Decade
Madelon M.E. de Jong
13 papers receiving 233 citations
Peers
Comparison fields: 5 of 41
- Hematology 131
- Molecular Biology 105
- Immunology 96
- Oncology 86
- Genetics 29
Countries citing papers authored by Madelon M.E. de Jong
This map shows the geographic impact of Madelon M.E. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madelon M.E. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madelon M.E. de Jong more than expected).
Fields of papers citing papers by Madelon M.E. de Jong
This network shows the impact of papers produced by Madelon M.E. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madelon M.E. de Jong. The network helps show where Madelon M.E. de Jong may publish in the future.
Co-authorship network of co-authors of Madelon M.E. de Jong
This figure shows the co-authorship network connecting the top 25 collaborators of Madelon M.E. de Jong. A scholar is included among the top collaborators of Madelon M.E. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madelon M.E. de Jong. Madelon M.E. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 14 | |
| 3 | 1 | |
| 4 | 19 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 25 | |
| 10 | 128 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 20 | |
| 14 | 1 |
About Madelon M.E. de Jong
Madelon M.E. de Jong is a scholar working on Hematology, Immunology and Oncology, having authored 14 papers that have together received 235 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Chemokine receptors and signaling (9 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Hematology (131 citations), Immunology (96 citations) and Oncology (86 citations). Madelon M.E. de Jong has collaborated with scholars based in Netherlands, Italy and Germany. Frequent co-authors include Tom Cupedo, Remco M. Hoogenboezem, Mathijs A. Sanders, Pieter C. van de Woestijne, Zoltán Kellermayer, Sabrin Tahri, Philippe Moreau, Pieter Sonneveld, Natalie Papazian and Mark van Duin. Their work appears in journals such as Blood, Nature reviews. Immunology and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.